Stryker (NYSE:SYK) Director Ronda Stryker Sells 50,000 Shares of Stock

Stryker Corporation (NYSE:SYK) Director Ronda Stryker sold 50,000 shares of the stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $340.10, for a total transaction of $17,005,000.00. Following the transaction, the director directly owned 2,251,375 shares in the company, valued at approximately $765,692,637.50. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Stryker Stock Down 3.5%

Shares of NYSE SYK traded down $12.01 during trading on Thursday, hitting $327.97. 2,232,012 shares of the company traded hands, compared to its average volume of 2,368,609. The firm has a market capitalization of $125.80 billion, a price-to-earnings ratio of 33.99, a P/E/G ratio of 2.11 and a beta of 0.76. The business’s fifty day moving average is $326.19 and its 200 day moving average is $332.95. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $396.86.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The company had revenue of $6.59 billion during the quarter, compared to the consensus estimate of $6.58 billion. During the same period last year, the business posted $3.13 EPS. The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities research analysts predict that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker’s dividend payout ratio (DPR) is currently 36.48%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Robert W. Baird set a $385.00 price objective on shares of Stryker in a report on Friday, May 1st. Citigroup reiterated a “buy” rating on shares of Stryker in a research note on Thursday, August 13th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Stryker in a report on Friday, May 1st. Canaccord Genuity Group dropped their target price on Stryker from $435.00 to $400.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Finally, Wolfe Research cut Stryker from an “outperform” rating to a “peer perform” rating in a research report on Thursday, August 13th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, Stryker currently has an average rating of “Moderate Buy” and a consensus target price of $386.28.

Hedge Funds Weigh In On Stryker

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Sankala Group LLC purchased a new stake in shares of Stryker during the fourth quarter valued at approximately $26,000. Godfrey Financial Associates Inc. bought a new position in Stryker in the 4th quarter valued at $26,000. United Financial Planning Group LLC purchased a new stake in shares of Stryker during the 3rd quarter valued at $27,000. Atlas Capital Advisors Inc. bought a new stake in shares of Stryker during the 4th quarter worth $27,000. Finally, Gables Capital Management Inc. bought a new stake in shares of Stryker during the 2nd quarter worth $25,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.